questions and answers
ADMIN
[COMPANY NAME] [Company address]
,Question 1. The 43-year-old patient comes into the clinic with flu-like symptoms. The patient's onset of
symptoms is less than 48 hours. The APN will prescribe oseltamivir and understands that the half-life is
which of the following?
1.
20 to 24 hours
2.
6 to 10 hours
3.
2.5 to 5 hours
4.
12 to 16 hours - Correct Answers: 2.
6 to 10 hours
Option 2:
The half-life for oseltamivir is 6 to 10 hours.
Rationales
Option 1:
The half-life for peramivir is 20 hours.
Option 3:
The half-life for zanamivir is 2.5 to 5.1 hours.
An APN is prescribing oseltamivir for the onset of flu-like symptoms to a 44-year-old patient. Which
dosage is appropriate for this patient?
1.
75 mg PO bid for 5 days and start within 48 hours of symptoms
2.
75 mg PO bid for 4 days and start within 48 hours of symptoms
3.
75 mg PO bid for 3 days and start within 48 hours of symptoms
4.
,75 mg PO bid for 2 days and start within 48 hours of symptoms - Correct Answers: 1.
75 mg PO bid for 5 days and start within 48 hours of symptoms
Option 1:
75 mg PO bid for 5 days and start within 48 hours of symptoms is the correct dosage and time frame.
The APN diagnosed a 54-year-old patient with onychomycosis. Which medication regimen is most
appropriate for this patient?
1.
Itraconazole 100 mg PO once daily with meal for 12 consecutive weeks
2.
Itraconazole 200 mg PO once daily with meal for 12 consecutive weeks
3.
Terbinafine 200 mg PO once daily with meal for 12 consecutive weeks
4.
Terbinafine 100 mg PO once daily with meal for 12 consecutive weeks - Correct Answers: 2.
Itraconazole 200 mg PO once daily with meal for 12 consecutive weeks
Option 2:
Itraconazole 200 mg PO once daily with meal for 12 consecutive weeks is the appropriate medication
and dosage.
Rationales
Option 1:
Itraconazole 100 mg PO once daily is too low a dosage for this patient.
Option 3:
Terbinafine 250 mg PO once daily for 6 weeks may be prescribed for onychomycosis.
Option 4:
Terbinafine 250 mg PO once daily for 6 weeks may be prescribed for onychomycosis.
When does the World Health Organization (WHO) endorse starting antiretroviral therapy (ART) in a
newly-diagnosed patient with HIV?
, 1.
Within 7 days to the same day of newly-diagnosed HIV patient
2.
Within 20 days of newly-diagnosed HIV patient
3.
After the viral load numbers
4.
Within 6 months of newly-diagnosed HIV patient - Correct Answers: 1.
Within 7 days to the same day of newly-diagnosed HIV patient
Option 1:
The WHO endorsed starting ART within 7 days of new diagnosis (WHO, 2017), including same day, citing
improved viral suppression.
Which characteristics of the patient with HIV must be known prior to starting abacavir specifically?
1.
HLA B*5701 testing
2.
Pretreatment CD4+ T cell count
3.
Pregnancy potential
4.
Cardiovascular disease - Correct Answers: 1.
HLA B*5701 testing
Option 1:
HLA B *5701 must be completed prior to starting abacavir because if the patient has a positive test, an
anaphylaxis can occur if the patient takes abacavir.
Rationales